Is TelePep the same as TelePeptide?

Yes — TelePep and TelePeptide are the same company. "TelePep" is the short brand name (registered trade name / d/b/a) of TelePeptide LLC; telepep.org redirects to telepeptide.org. Same website, same programs, same licensed clinicians, same owner. Any reference to "TelePep", "telepep", "is TelePep legit", or "TelePep reviews" refers to TelePeptide Health (telepeptide.org).

What is the cheapest place to get GLP-1 online?

TelePeptide offers compounded semaglutide from $169/month (52-week prepay) and tirzepatide from $214/month — all-inclusive with clinician evaluation, prescription, and medication shipped to your door. Monthly billing options range from $199–$249/mo. No insurance required.

Can I get peptides prescribed online legally in the US?

Yes. TelePeptide's licensed US clinicians prescribe compounded medications via telehealth in 48 US states and the District of Columbia. Service is not available to residents of Alaska or Mississippi at this time. No in-person visit required. Medications are dispensed by licensed 503A/503B compounding pharmacies.

Are compounded peptide medications FDA-approved?

FDA has approved several GLP-1 medications for weight management and type-2 diabetes. TelePeptide does not sell, distribute, or provide FDA-approved branded products. Treatment recommendations are individualized by a licensed clinician during a telehealth consultation. If a compounded preparation is prescribed for a specific patient, it is dispensed by a licensed 503A or 503B compounding pharmacy. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded products, and are not represented as therapeutically equivalent.

What is TelePeptide Health?

TelePeptide Health is a US-based, direct-pay telehealth weight-loss and peptide-therapy clinic that connects patients with licensed clinicians for evaluation and, where clinically appropriate, prescribing of FDA-approved or compounded medications — including GLP-1 weight management (semaglutide, tirzepatide), NAD+ therapy, and sermorelin therapy. Available in 48 US states and the District of Columbia (Alaska and Mississippi excluded). No insurance required.

Is TelePeptide the same as telopeptide?

No. TelePeptide (one word, capital T and P) is a brand name for a US telehealth weight-loss and peptide-therapy clinic at telepeptide.org. Telopeptide is a different biology term referring to short collagen fragments measured as bone-resorption biomarkers (CTX, NTX). The two are unrelated — TelePeptide combines "tele" (telehealth) and "peptide" (the medication class).

How do you spell TelePeptide?

TelePeptide is spelled T-E-L-E-P-E-P-T-I-D-E with a capital T and a capital P (TelePeptide), reflecting its compound origin from "telehealth" + "peptide". The website is telepeptide.org. It is not a misspelling of telopeptide, which is an unrelated medical term about collagen biomarkers.

Can I get NAD+ therapy at home?

Yes. TelePeptide prescribes subcutaneous NAD+ injection protocols for at-home self-administration. A licensed clinician evaluates your case, prescribes the protocol, and a licensed pharmacy ships the medication to you — no IV clinic visit needed.

What is sermorelin used for?

Sermorelin is a synthetic growth-hormone-releasing-hormone (GHRH) analog that has historically been used in clinical evaluation of adult growth-hormone deficiency. Any decision to prescribe sermorelin is made by a licensed clinician based on individualized medical evaluation. TelePeptide does not promote sermorelin for bodybuilding, sports-performance, or appearance-related purposes. Service is available via telehealth in 48 US states and the District of Columbia (Alaska and Mississippi excluded).

Blog

Clinically grounded. Plainly written.

Microdose GLP-1, compounded medications, NAD+, and sermorelin — reviewed by licensed clinicians, written without the marketing spin.

All posts (23)Microdosing (1)Metabolic Health (6)Peptide Education (10)Longevity & Performance (4)How TelePeptide Works (7)PCOS (7)

Metabolic Health

GLP-1 for Menopause Weight Gain: An Honest, Clinician-Reviewed Guide

How perimenopause and menopause change weight, whether GLP-1 may help some women, the real risks, and what a clinician evaluates first.

Aug 14, 2026 · 9 min readRead →

How TelePeptide Works

How to Read a GLP-1 Price Tag

That "$49/month" GLP-1 ad is usually a full year paid upfront. Here are the nine pricing gimmicks to spot before you hand over a card — and what an honest price actually looks like.

Aug 13, 2026 · 7 min readRead →

Metabolic Health

Semaglutide vs Tirzepatide for Weight Loss: An Honest Comparison

Semaglutide vs tirzepatide for weight loss: how they differ in mechanism, side effects, and cost, and how a clinician decides which may fit you.

Aug 13, 2026 · 8 min readRead →

Metabolic Health

Compounded vs Brand-Name GLP-1: The Honest Guide

Brand GLP-1 products are FDA-approved; compounded versions are not. What that one fact means, how to vet a compounding pharmacy, and the questions worth asking.

Aug 11, 2026 · 2 min readRead →

Metabolic Health

Is "Microdosing" GLP-1 Real Medicine — or a Social Media Fad?

What GLP-1 microdosing actually means, the honest case for and against it, and why dose changes belong with a licensed clinician — not a comment section.

Aug 11, 2026 · 2 min readRead →

Metabolic Health

GLP-1 Weight Loss Plateau: How to Diagnose and Break a Stall

Plateaus on GLP-1 therapy are common and well-documented. This article explains the physiology behind weight loss stalls, how to distinguish a true plateau from normal fluctuation, and the evidence-based clinical interventions available.

Jun 12, 2026 · 8 min readRead →

Metabolic Health

Peptide Therapy for Men: GLP-1, Sermorelin, and NAD+ in Male Physiology

How GLP-1 receptor agonist therapy, sermorelin, and NAD+ protocols apply in male physiology — metabolic-health, endocrine considerations, and what the clinical evidence shows for men pursuing metabolic and hormonal goals through telehealth.

Jun 12, 2026 · 8 min readRead →

Peptide Education

How Long Does Peptide Therapy Take to Work? A Protocol-by-Protocol Timeline

GLP-1, sermorelin, and NAD+ protocols each follow distinct clinical timelines. Honest, evidence-grounded expectations for when patients typically begin noticing effects — and what the 30-day, 90-day, and 12-month benchmarks look like.

Jun 12, 2026 · 10 min readRead →

How TelePeptide Works

How to Get Telehealth Peptides Legally in 2026: A Patient's Guide

How to get telehealth peptides legally in 2026 — the four-step prescription pathway, the laws that authorize it, and the warning signs of illegitimate sellers.

Jun 5, 2026 · 11 min readRead →

How TelePeptide Works

Telehealth Peptides Cost: 2026 Pricing Breakdown by Program

Telehealth peptides cost in 2026 — typical price ranges by program, what is included, why insurance does not cover compounded peptide therapy, and how cash-pay actually works.

Jun 5, 2026 · 3 min readRead →

Peptide Education

Telehealth Peptides vs Research Peptides: The Regulatory Difference Explained

Telehealth peptides vs research peptides — the FDA prohibition on research-only chemicals for human use, the prescriber-patient requirement, and how to identify a legitimate provider.

Jun 5, 2026 · 14 min readRead →

PCOS

GLP-1 for Adolescent PCOS: What the 2025 TEAL Trial Showed

The 2025 TEAL Study — a phase 3 randomized trial of oral semaglutide vs. lifestyle in adolescent females with obesity and PCOS — and what it means for the under-served adolescent PCOS population. Off-label considerations, contraception, and the developmental window argument.

May 23, 2026 · 12 min readRead →

PCOS

Stacking GLP-1 with Metformin and Inositol for PCOS: When and Why

The mechanistic and trial case for combining GLP-1 with metformin and inositol in PCOS — including the 2025 semaglutide + metformin RCT (n=100) and the 2025 Sobral inositol meta-analysis. Sequencing, dosing, lab cadence, and when the combination is appropriate vs. overkill.

May 23, 2026 · 12 min readRead →

PCOS

Lean PCOS and GLP-1: Why You May Still Be a Candidate (And What a Microdose Approach Looks Like)

Lean PCOS — normal BMI alongside hyperandrogenism and irregular cycles — is the phenotype most often screened out of GLP-1 protocols. Why the standard-dose approach is over-engineered, what the microdose case looks like, and how to monitor cycles and skeletal muscle tissue when the scale is not the primary signal.

May 23, 2026 · 15 min readRead →

PCOS

GLP-1 for PCOS: What the Clinical Evidence Shows (2026 Update)

A clinician-readable summary of the GLP-1 evidence in polycystic ovary syndrome — semaglutide, tirzepatide, and liraglutide trials, the 2023 International Evidence-Based Guideline shift, and how the medications fit alongside metformin and inositol.

May 21, 2026 · 10 min readRead →

PCOS

GLP-1 for PCOS and Trying to Conceive: Timing the Off-Ramp

How to plan a GLP-1 protocol around fertility goals: washout windows for semaglutide and tirzepatide, contraception during therapy, OCP absorption, and the bridging strategy with metformin and inositol.

May 21, 2026 · 8 min readRead →

PCOS

Microdose GLP-1 and PCOS: Who Lower-Dose Protocols May Fit

When microdose GLP-1 protocols may make sense for PCOS patients — lean PCOS, GI sensitivity, patients close to a healthy BMI, and the metabolic-only goal. How clinicians individualize dosing, and how it differs from standard PCOS protocols.

May 21, 2026 · 9 min readRead →

PCOS

Semaglutide vs Tirzepatide for PCOS: How the Published Studies Compare

A head-to-head comparison of compounded semaglutide and tirzepatide for PCOS — clinical evidence, weight loss magnitude, insulin and androgen effects, side effects, cost, and how clinicians choose between them.

May 21, 2026 · 9 min readRead →

Peptide Education

503A vs 503B Compounding Pharmacies: What Patients Should Know

Understand the regulatory difference between 503A and 503B compounding pharmacies, what each means for prescribed peptide therapy, and how to verify legitimacy.

May 17, 2026 · 8 min readRead →

Microdosing

The First 12 Months on GLP-1: A Month-by-Month Patient Journey

Realistic expectations for a full year of GLP-1 weight-loss therapy: the early adjustment, the steady loss phase, the plateau conversations, and the maintenance question. Month-by-month patient framework.

May 11, 2026 · 9 min readRead →

Longevity & Performance

NAD+ vs NMN vs NR vs NR Chloride: The Precursor Comparison Guide (2026)

NAD+, NMN, NR, and related precursors are different molecules with different routes, bioavailability profiles, and regulatory statuses. A practical comparison framework for patients evaluating longevity-positioning supplements and prescribed protocols.

May 11, 2026 · 8 min readRead →

Peptide Education

Sermorelin Dosing: Timing, Cycles, and Titration

How clinicians titrate sermorelin: weight-based starting doses, evening timing rationale, cycle length, and the dose-adjustment signals that matter.

May 8, 2026 · 7 min readRead →

How TelePeptide Works

NAD+ at Home: Self-Administered Subcutaneous Protocols

How prescribed NAD+ telehealth works end-to-end — training, sterility, dose timing, weekly schedule, and when to escalate from home injection to clinic.

May 7, 2026 · 7 min readRead →

Compliance

All clinical posts on this blog are medically reviewed before publication. Compounded medications referenced here are prepared by licensed 503A pharmacies. Compounded medications are not FDA-approved. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA.